AzTrials
AzTrials

Eye DiseasesNCT04497207

Deep Learning for Classification of Scheimpflug Corneal Tomography Images

An observational study of Eye Diseases, run by Assiut University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Keratoconus is a common disorder. An early diagnosis influences the disease prognosis in the affected patients and prevents postoperative complications in patients with keratoconus considering refractive surgery. Machine learning approaches have been widely used for image classification. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Eye Diseases
What is being tested?
Scheimpflug Camera Corneal Tomography
How many people
1,669 participants
Where
1 siteEgypt
Study dates
10 Aug 2020to 25 Aug 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Patients with keratoconus, subclinical keratoconus \& normal individuals from refractive surgery candidates.

Who may be able to join

  • Keratoconus group:
  • Presence of a central protrusion of the cornea with Fleischer ring, Vogt striae, or both by slitlamp examination.
  • irregular cornea determined by distorted keratometry mires and distortion of retinoscopic red reflex or both in addition to the following topographic findings as summarized by Pińero and colleagues :
  • focal steepening located in a zone of protrusion surrounded by concentrically decreasing power zones
  • focal areas with diopteric (D) values >47.0D
  • inferior- superior(I-S) asymmetry measured to be > 1.4 D
Show all 14Show fewer
  • Angling of the hemimeridians in an asymmetric or broken bowtie pattern with skewing of the steepest radial axis(SRAX) .
  • Suspicious group:
  • Defined as subtle corneal tomographic changes as the aforementioned keratoconus abnormalities in the absence of slit- lamp or visual acuity changes typical of keratoconus (forme fruste keratoconus).
  • Normal group:
  • Refractive surgery candidates
  • Refractive error of less than 8.0 D sphere
  • Less than 3.0 D of astigmatism
  • without clinical, topographic or tomographic signs of keratoconus or suspect keratoconus.

Who cannot join

  • Systemic disease
  • Other corneal disease such as pellucid marginal degeneration
  • History of trauma
  • Corneal surgery such as corneal cross- linking for progressive keratoconus.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Medicine

    Asyut, 71515

Other trials in Egypt

About this study

Official title: Classification of Color-Coded Scheimpflug Camera Corneal Tomography Images Using Deep Learning

Keratoconus is a common disorder. An early diagnosis influences the disease prognosis in the affected patients and prevents postoperative complications in patients with keratoconus considering refractive surgery. Machine learning approaches have been widely used for image classification. Here, we will assess the ability of deep learning to enable high-performance image classification of the color-coded corneal maps obtained by Scheimpflug camera in patients with keratoconus, subclinical keratoconus, and normal individuals.

Conditions
Eye Diseases
Being tested
Scheimpflug Camera Corneal Tomography
Keywords
Keratoconus, Deep learning, Scheimpflug camera, Corneal tomography
Medical subject headings
Eye Diseases, Keratoconus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Scheimpflug Camera Corneal TomographyOther

    Pentacam Sheimpflug system(Pentacam HR, Oculus Optikgeräte GmbH, software V.1.15r4 n7) is used for imaging of the anterir and posterior surfaces of the cornea to obtain corneal tomographic maps.

Study groups in NCT04497207
Study groupRoleWhat they receive
KeratoconusThose with a clinical diagnosis of keratoconus such as: a) the presence of a central protrusion of the cornea with Fleischer ring, Vogt striae, or both by slitlamp examination.(b) an irregular cornea determined by distorted keratometry mires and distortion of retinoscopic red reflex or both in addition to the following topographic findings as summarized by Pińero and colleagues: focal steepening located in a zone of protrusion surrounded by concentrically decreasing power zones, focal areas with dioptric (D) values >47.0D, inferior- superior(I-S) asymmetry measured to be > 1.4 D or angling of the hemimeridians in an asymmetric or broken bowtie pattern with skewing of the steepest radial axis (SRAX) 2.
Receives: Other: Scheimpflug Camera Corneal Tomography
Subclinical keratoconusDefined as subtle corneal tomographic changes as the aforementioned keratoconus abnormalities in the absence of slit- lamp or visual acuity changes typical of keratoconus (subclinical keratoconus).
Receives: Other: Scheimpflug Camera Corneal Tomography
NormalThis group comprised refractive surgery candidates and subjects applying for a contact lens fitting with a refractive error of less than 8.0 D sphere with less than 3.0 D of astigmatism and without clinical, topographic or tomographic signs of keratoconus nor suspected keratoconus.
Receives: Other: Scheimpflug Camera Corneal Tomography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Croppedm denoised, and resized to obtain four separate image stacks of 256×256 pixels

    Measured: 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2020
  2. Study start10 Aug 2020
  3. Primary completion20 Aug 2020
  4. Study completion25 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
1,669 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04497207
Sponsor's protocol ID
17300437
Status last verified
Oct 2020
First submitted
30 Jul 2020
Last updated
6 Oct 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Eye Diseases, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Croppedm denoised, and resized to obtain four separate image stacks of 256×256 pixels (time frame: 2 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in